node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
Agtr1a | Serpine1 | ENSRNOP00000034687 | ENSRNOP00000001916 | Type-1A angiotensin II receptor; Receptor for angiotensin II. Mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system; Belongs to the G-protein coupled receptor 1 family | Plasminogen activator inhibitor 1; Serine protease inhibitor. Inhibits TMPRSS7. Is a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase- type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots. As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading. Acts as a regulator of cell migration, independently of its role as protease inhibitor. It is required for stimulation of keratinocyte migration during cutaneous injury repair. I [...] | 0.909 |
Lrp1 | Plat | ENSRNOP00000034210 | ENSRNOP00000025764 | Low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor); Low density lipoprotein receptor-related protein 1 | Tissue-type plasminogen activator; Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events; Belongs to the peptidase S1 family | 0.992 |
Lrp1 | Plau | ENSRNOP00000034210 | ENSRNOP00000014273 | Low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor); Low density lipoprotein receptor-related protein 1 | Plasminogen activator, urokinase; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin | 0.909 |
Lrp1 | Plaur | ENSRNOP00000034210 | ENSRNOP00000063960 | Low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor); Low density lipoprotein receptor-related protein 1 | Plasminogen activator, urokinase receptor; Acts as a receptor for urokinase plasminogen activator. Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA | 0.898 |
Lrp1 | Plg | ENSRNOP00000034210 | ENSRNOP00000023370 | Low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor); Low density lipoprotein receptor-related protein 1 | Plasminogen; Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invasion may be modulated b [...] | 0.570 |
Lrp1 | Serpine1 | ENSRNOP00000034210 | ENSRNOP00000001916 | Low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor); Low density lipoprotein receptor-related protein 1 | Plasminogen activator inhibitor 1; Serine protease inhibitor. Inhibits TMPRSS7. Is a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase- type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots. As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading. Acts as a regulator of cell migration, independently of its role as protease inhibitor. It is required for stimulation of keratinocyte migration during cutaneous injury repair. I [...] | 0.954 |
Lrp1 | Serpine2 | ENSRNOP00000034210 | ENSRNOP00000020919 | Low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor); Low density lipoprotein receptor-related protein 1 | Serpin family e member 2; Serine protease inhibitor with activity toward thrombin, trypsin, and urokinase. Promotes neurite extension by inhibiting thrombin. Binds heparin | 0.834 |
Plat | Lrp1 | ENSRNOP00000025764 | ENSRNOP00000034210 | Tissue-type plasminogen activator; Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events; Belongs to the peptidase S1 family | Low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor); Low density lipoprotein receptor-related protein 1 | 0.992 |
Plat | Plaur | ENSRNOP00000025764 | ENSRNOP00000063960 | Tissue-type plasminogen activator; Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events; Belongs to the peptidase S1 family | Plasminogen activator, urokinase receptor; Acts as a receptor for urokinase plasminogen activator. Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA | 0.839 |
Plat | Plg | ENSRNOP00000025764 | ENSRNOP00000023370 | Tissue-type plasminogen activator; Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events; Belongs to the peptidase S1 family | Plasminogen; Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invasion may be modulated b [...] | 0.943 |
Plat | Serpine1 | ENSRNOP00000025764 | ENSRNOP00000001916 | Tissue-type plasminogen activator; Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events; Belongs to the peptidase S1 family | Plasminogen activator inhibitor 1; Serine protease inhibitor. Inhibits TMPRSS7. Is a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase- type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots. As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading. Acts as a regulator of cell migration, independently of its role as protease inhibitor. It is required for stimulation of keratinocyte migration during cutaneous injury repair. I [...] | 0.999 |
Plat | Serpine2 | ENSRNOP00000025764 | ENSRNOP00000020919 | Tissue-type plasminogen activator; Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events; Belongs to the peptidase S1 family | Serpin family e member 2; Serine protease inhibitor with activity toward thrombin, trypsin, and urokinase. Promotes neurite extension by inhibiting thrombin. Binds heparin | 0.986 |
Plat | Vldlr | ENSRNOP00000025764 | ENSRNOP00000036229 | Tissue-type plasminogen activator; Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events; Belongs to the peptidase S1 family | Very low density lipoprotein receptor; Binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation (By similarity) | 0.566 |
Plat | Vtn | ENSRNOP00000025764 | ENSRNOP00000046415 | Tissue-type plasminogen activator; Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events; Belongs to the peptidase S1 family | Vitronectin, isoform CRA_b; Vitronectin | 0.736 |
Plau | Lrp1 | ENSRNOP00000014273 | ENSRNOP00000034210 | Plasminogen activator, urokinase; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin | Low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor); Low density lipoprotein receptor-related protein 1 | 0.909 |
Plau | Plaur | ENSRNOP00000014273 | ENSRNOP00000063960 | Plasminogen activator, urokinase; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin | Plasminogen activator, urokinase receptor; Acts as a receptor for urokinase plasminogen activator. Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA | 0.999 |
Plau | Plg | ENSRNOP00000014273 | ENSRNOP00000023370 | Plasminogen activator, urokinase; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin | Plasminogen; Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invasion may be modulated b [...] | 0.972 |
Plau | Serpine1 | ENSRNOP00000014273 | ENSRNOP00000001916 | Plasminogen activator, urokinase; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin | Plasminogen activator inhibitor 1; Serine protease inhibitor. Inhibits TMPRSS7. Is a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase- type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots. As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading. Acts as a regulator of cell migration, independently of its role as protease inhibitor. It is required for stimulation of keratinocyte migration during cutaneous injury repair. I [...] | 0.999 |
Plau | Serpine2 | ENSRNOP00000014273 | ENSRNOP00000020919 | Plasminogen activator, urokinase; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin | Serpin family e member 2; Serine protease inhibitor with activity toward thrombin, trypsin, and urokinase. Promotes neurite extension by inhibiting thrombin. Binds heparin | 0.990 |
Plau | Vldlr | ENSRNOP00000014273 | ENSRNOP00000036229 | Plasminogen activator, urokinase; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin | Very low density lipoprotein receptor; Binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation (By similarity) | 0.734 |